June 19th 2019: PD Neurotechnology certified by DQS Med with the CE Certificate Class IIa for PDMonitor.

PD Neurotechnology (PDN) has been certified by DQS Med with the CE Certificate Class IIa for its groundbreaking wearable medical device for continuous monitoring of patients with Parkinson's Disease, PDMonitor®.PDN has  implemented and maintains a quality assurance system which applies to the final controls of the product. Through an audit, documented in a report, performed by DQS Medizinprodukte GmbH, it was verified that the company's quality assurance system fulfills the requirements of Annex VI of Council Directive 93/42/EEC concerning medical devices with respect to PDMonitor®.

Prof Dimitris Fotiadis, R&D Director and Co-Founder of PDN, commented: “We are very proud to receive the CE marking certificate for PDMonitor®. It is a great milestone achieved, validating once again our vision and the team’s and company’s capabilities and performance”.

You can find the press release here.